Amgen Competitors

Stocks . Germany . 
Stock . Amgen Inc
AMG Stock  EUR 266.35  1.15  0.43%   
Amgen Inc competes with Strategic Investments, REINET INVESTMENTS, PennantPark Investment, NEWELL RUBBERMAID, and GOODYEAR T; as well as few others. The company operates under Other sector and is part of Other industry. Analyzing Amgen competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Amgen to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Amgen Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Amgen competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
264.67266.35268.03
Details
Intrinsic
Valuation
LowRealHigh
228.57230.25292.99
Details
Naive
Forecast
LowNextHigh
270.09271.77273.45
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
256.93270.05283.16
Details

Amgen Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Amgen and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Amgen and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Amgen Inc does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
7SU
+ 0.95
NWL
7SU
+ 0.87
GTR
GTR
+ 0.83
NWL
E5M
+ 0.82
7SU
7SU
+ 0.81
12P
E5M
+ 0.81
12P
  
High negative correlations   
GTR
- 0.33
DNN
7SU
- 0.3
DNN
NWL
- 0.24
DNN
E5M
- 0.23
DNN
12P
- 0.16
DNN
RNT
- 0.13
DNN

Risk-Adjusted Indicators

There is a big difference between Amgen Stock performing well and Amgen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Amgen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Amgen Competitive Analysis

The better you understand Amgen competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Amgen's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Amgen's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
AMG DNN RNT 12P NWL GTR 6BC0 7SU E5M
 0.43 
 266.35 
Amgen
 7.69 
 0.14 
Strategic
 2.42 
 24.20 
REINET
 0.16 
 6.32 
PennantPark
 0.11 
 8.93 
NEWELL
 1.60 
 10.14 
GOODYEAR
 0.00 
 0.11 
EAT
 0.41 
 48.20 
Summit
 0.69 
 292.00 
EAGLE
Market Volatility
(90 Days Market Risk)
Very steady
Out of control
Not too volatile
Somewhat reliable
Somewhat reliable
Somewhat reliable
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
Weak
Weak
Insignificant
Good
Good
Very Weak
Good
Good
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Low
Low
Quite High
Low
Low
Quite High
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Fairly Valued
Under Valued
Over Valued
Over Valued
Under Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
N/A
68.57
N/A
1.04
N/A
N/A
N/A
N/A
N/A
Net Asset
65.12 B
455.94 M
N/A
1.32 B
13.26 B
22.43 B
N/A
4.26 B
2.58 B
Profit Margin
N/A
0.65
1.24
N/A
N/A
N/A
N/A
N/A
N/A
EBITDA
12.17 B
N/A
N/A
N/A
688 M
1.81 B
N/A
660.96 M
634.82 M
Current Valuation
163.09 B
(74.16 M)
N/A
N/A
10.91 B
10.91 B
N/A
4.46 B
5.81 B
Price To Book
39.37
1.04
N/A
N/A
1.47
0.59
N/A
1.84
4.37
Operating Margin
N/A
0.83
0.99
N/A
N/A
N/A
-1.64
N/A
N/A
Five Year Return
N/A
N/A
N/A
12.16
N/A
N/A
N/A
N/A
N/A
Beta
N/A
0.21
0.56
0.25
N/A
N/A
0.0591
N/A
N/A
Number Of Employees
20
3
N/A
7
N/A
N/A
N/A
N/A
N/A
Shares Outstanding
N/A
337.5 M
181.79 M
N/A
N/A
N/A
156.77 M
N/A
N/A
Cash Flow From Operations
9.72 B
68.77 M
N/A
(19.4 M)
(272 M)
521 M
N/A
284.1 M
517.17 M
Annual Yield
0.0224
0.0164
0.0165
0.02
0.0584
0.0887
N/A
N/A
0.0078
Total Debt
37.35 B
1.82 M
N/A
504.34 M
4.76 B
7.27 B
N/A
1.49 B
938.26 M
Return On Equity
N/A
0.0565
0.15
N/A
N/A
N/A
-4.7
N/A
N/A
Z Score
1.2
18.0
N/A
N/A
0.6
N/A
N/A
1.2
3.6
Return On Asset
N/A
0.035
0.0742
N/A
N/A
N/A
-0.082
N/A
N/A
Book Value Per Share
N/A
1.09
29.93
9.11
N/A
N/A
0.082
N/A
N/A
Total Asset
65.12 B
455.94 M
N/A
1.32 B
13.26 B
22.43 B
N/A
4.26 B
2.58 B
Last Dividend Paid
1.6
0.02
0.28
0.6
0.23
0.16
N/A
N/A
N/A
Debt To Equity
N/A
14.3
N/A
80.1
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
N/A
0.29
39.76
N/A
N/A
N/A
0.01
N/A
N/A
Market Capitalization
105.18 B
54.95 M
3.24 B
402.53 M
8.41 B
5.48 B
23.44 M
4.19 B
5.93 B
Price To Earnings To Growth
1.54
N/A
N/A
N/A
N/A
N/A
N/A
1.44
N/A
Price To Earning
N/A
149.0
N/A
9.21
N/A
N/A
N/A
N/A
N/A
Price To Sales
5.61
1.75
N/A
N/A
0.57
0.15
N/A
1.5
2.61
Net Income
6.55 B
66.62 M
N/A
(24.74 M)
197 M
202 M
N/A
272.14 M
374.25 M
Earnings Per Share
N/A
0.01
4.09
N/A
N/A
N/A
-0.47
N/A
N/A
Shares Owned By Insiders
N/A
71.12
24.9
N/A
N/A
N/A
11.95
N/A
N/A
Revenue
26.32 B
72.29 M
611 M
N/A
9.46 B
20.8 B
4.38 M
2.41 B
1.86 B
Cash And Equivalents
N/A
40.61 M
N/A
19.51 M
N/A
N/A
N/A
N/A
N/A
Cash Per Share
N/A
0.12
N/A
0.28
N/A
N/A
N/A
N/A
N/A
Gross Profit
N/A
74.78 M
604 M
N/A
N/A
N/A
897.94 K
N/A
N/A
Day Typical Price
266.35
0.14
24.2
6.32
8.93
10.12
0.11
48.2
290.67
Accumulation Distribution
N/A
N/A
N/A
N/A
N/A
0.0302
N/A
N/A
0.0137
Market Facilitation Index
N/A
N/A
N/A
N/A
N/A
0.31
N/A
N/A
4.0
Daily Balance Of Power
9.2 T
9.2 T
(9,223,372,036,855)
(9,223,372,036,855)
(9,223,372,036,855)
0.5161
0.0
(9,223,372,036,855)
0.5
Period Momentum Indicator
1.15
0.01
(0.60)
(0.01)
(0.01)
0.16
N/A
(0.20)
2.0
Rate Of Daily Change
1.0
1.08
0.98
1.0
1.0
1.02
1.0
1.0
1.01
Day Median Price
266.35
0.14
24.2
6.32
8.93
10.12
0.11
48.2
290.0
Price Action Indicator
0.58
0.005
(0.30)
(0.01)
(0.01)
0.11
N/A
(0.10)
3.0
Relative Strength Index
61.69
51.84
52.67
66.29
69.57
68.93
N/A
71.31
70.49
Coefficient Of Variation
(1,133)
4847.27
2865.71
1762.36
666.05
696.99
N/A
509.08
535.69
Mean Deviation
1.15
1.8
1.8
1.09
2.39
2.28
N/A
1.8
1.41
Jensen Alpha
(0.27)
0.0361
0.0728
0.0232
0.5277
0.3648
N/A
0.4791
0.2939
Total Risk Alpha
(0.44)
(0.65)
(0.40)
(0.19)
(0.07)
(0.08)
N/A
0.0651
0.0306
Sortino Ratio
N/A
(0.01)
(0.01)
(0.03)
0.194
0.1108
N/A
0.1937
0.1277
Downside Variance
N/A
73.77
11.55
2.0
5.16
6.97
N/A
3.5
3.73
Standard Deviation
1.69
4.38
2.93
1.61
3.85
3.0
N/A
2.54
2.06
Kurtosis
3.68
12.14
2.67
6.82
18.24
0.776
N/A
2.51
6.13
Potential Upside
1.95
7.14
5.69
2.8
5.76
6.38
N/A
6.49
3.67
Treynor Ratio
(0.19)
0.2319
0.6071
0.1786
1.78
0.9679
N/A
5.77
0.5947
Maximum Drawdown
9.33
35.58
16.7
10.56
28.1
12.74
N/A
11.33
12.41
Variance
2.84
19.17
8.57
2.59
14.84
8.99
N/A
6.48
4.24
Market Risk Adjusted Performance
(0.18)
0.2419
0.6171
0.1886
1.79
0.9779
N/A
5.78
0.6047
Risk Adjusted Performance
(0.06)
0.024
0.0341
0.0486
0.1228
0.1171
N/A
0.1572
0.149
Skewness
(1.46)
1.89
0.1684
1.47
3.25
0.733
N/A
1.19
1.39
Semi Deviation
N/A
2.72
2.38
1.27
2.0
2.22
N/A
1.39
1.34
Information Ratio
(0.17)
(0.01)
(0.01)
(0.03)
0.1144
0.0976
N/A
0.1424
0.1198
Value At Risk
(4.02)
(7.14)
(6.45)
(2.39)
(3.22)
(3.77)
N/A
(2.37)
(2.63)
Expected Short fall
N/A
(9.98)
(2.93)
(1.25)
(3.03)
(2.40)
N/A
(2.35)
(1.88)
Downside Deviation
N/A
8.59
3.4
1.42
2.27
2.64
N/A
1.87
1.93
Semi Variance
N/A
7.41
5.67
1.62
4.01
4.91
N/A
1.94
1.8

Amgen Competition Performance Charts

Five steps to successful analysis of Amgen Competition

Amgen's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Amgen Inc in relation to its competition. Amgen's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Amgen in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Amgen's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Amgen Inc, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Amgen position

In addition to having Amgen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Machinery Thematic Idea Now

Machinery
Machinery Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Machinery theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Machinery Theme or any other thematic opportunities.
View All  Next Launch

Additional Information and Resources on Investing in Amgen Stock

When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
How To Invest In Amgen
Details
Is Amgen Stock a good investment?
Details
What is Amgen's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out Amgen Correlation with its peers.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Altman
Z Score
Details
Intrinsic
Valuation
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY